Related Experiment Video
Updated: May 1, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
19.1K
Metabolic syndrome in migraine headache: A case-control study
Mehrzad Salmasi1, Laya Amini1, Shaghayegh Haghjooy Javanmard2
1Isfahan Neurosciences Research Center, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran.
Summary
Metabolic syndrome was not significantly correlated with migraine headaches in this study. However, higher body mass index and waist circumference were more frequent in migraine patients.
Area of Science:
- Neurology
- Endocrinology
- Public Health
Background:
- Previous studies explored the link between metabolic syndrome and migraine.
- No studies have directly compared metabolic syndrome prevalence in migraine patients versus controls.
- Controlling metabolic syndrome may reduce therapeutic resistance in migraine patients.
Purpose of the Study:
- To compare the prevalence of metabolic syndrome in patients with and without migraine headaches.
- To investigate potential correlations between metabolic syndrome and migraine.
Main Methods:
- 200 patients diagnosed with migraine according to International Headache Society criteria were enrolled.
- 200 healthy individuals without migraine served as controls.
- Metabolic syndrome was diagnosed using ATP III criteria in both groups and compared.
Main Results:
- Metabolic syndrome prevalence was 17% in migraine patients and 15% in controls (P = 0.585).
- Body mass index (P = 0.05) and waist circumference (P = 0.03) were significantly more frequent in migraine patients.
Conclusions:
- No significant overall correlation was found between metabolic syndrome and migraine headache.
- Specific metabolic syndrome components, namely higher body mass index and waist circumference, showed a correlation with migraine.
Related Concept Videos
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:19Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
886
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
01:19Overview of Carbohydrate Metabolism
4.5K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.5K
01:19Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28